A phase II NCCTG/CALGB trial of imatinib (STI571) in patients (pts) with c-kit-expressing relapsed small cell lung cancer (SCLC)
Year: 2005
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Mayo Clinic, Mayo Clinic in Arizona
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2275487949
